Items where Subject is "B000 Health Professions > B200 Pharmacology Toxicology and Pharmacy > B210 Pharmacology and Therapeutics"

Chapter in book

Sarker, D.K. (2004) Quality control, analytical validation and pharmacopoeial testing In: Future drug discovery 2004. Touch Group PLC, UK, pp. 38-41.

Journal article

Arenas-Lopez, Sara, Riphagen, Shelley, Tibby, Shane M., Durward, Andrew, Tomlin, Steve, Davies, Graham and Murdoch, Ian A. (2004) Use of oral clonidine for sedation in ventilated paediatric intensive care patients Intensive Care Medicine, 30 (8). pp. 1625-1629. ISSN 1432-1238

Banchonglikitkul, C., Smart, J.D., Gibbs, R.V., Donovan, S.J. and Cook, D.J. (2002) An in-vitro evaluation of lectin cytotoxicity using cell lines derived from the ocular surface Journal of Drug Targeting, 10 (8). pp. 601-606. ISSN 1061-186X

CHATTERJEE, PRABAL (2010) Hepatic inflammation and insulin resistance in pre-diabetes – further evidence for the beneficial actions of PPAR-γ agonists and a role for SOCS-3 modulation British Journal of Pharmacology, 160 (8). pp. 1889-1891. ISSN 0007-1188

Chatterjee, P.K., Patel, N.S.A., Kvale, E.O., Brown, P.A.J., Stewart, K.N., Mota-Filipe, H., Sharpe, M.A., Di Paola, R., Cuzzocrea, S. and Thiemermann, C. (2004) EUK-134 reduces renal dsyfunction and injury caused by oxidative and nitrosative stress of the kidney American Journal of Nephrology, 24. pp. 165-177. ISSN 0250-8095

Cuzzocrea, S., Rossi, B., Di Paola, R., Genovese, T., Patel, N.S.A., Cuzzocrea, E., Ianaro, A., Sautebin, L., Fulia, F., Chatterjee, P.K., Caputi, A.P. and Thiemermann, C. (2003) Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice Intensive care medicine, 29. pp. 2016-2025. ISSN 0342-4642

Dugo, L., Chatterjee, P.K., Mazzon, E., McDonald, M.C., Di Paola, R., Fulia, F., Caputi, A.P., Thiemermann, C. and Cuzzocrea, S. (2002) The tyrosine kinase inhibitor tyrphostin AG 126 reduced the multiple organ failure induced by zymosan in the rat Intensive Care Medicine, 28 (6). pp. 775-788. ISSN 0342-4642

Friedman, M.A., Detweiler-Bedell, J.B., Leventhal, H.E., Horne, R., Keitner, G.I. and Miller, I.W. (2004) Combined psychotherapy and pharmacotherapy for the treatment of major depressive disorder Clinical Psychology: Science and Practice, 11 (1). pp. 47-68. ISSN 0969-5893

Gard, P.R. and Rusted, J.M. (2004) Angiotensin and Alzheimer´s disease: therapeutic prospects Expert Review of Neurotherapeutics, 4 (1). pp. 87-96.

Gbadamosi, J.K., Hunter, A.C. and Moghimi, S.M. (2002) PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance FEBS Letters, 532 (3). pp. 338-344. ISSN 0014-5793

Izumi, M., McDonald, M.C., Sharpe, M.A., Chatterjee, P.K. and Thiemermann, C. (2002) Superoxide dismutase mimetics with catalase activity reduce the organ injury in hemorrhagic shock Shock, 18 (3). pp. 230-235. ISSN 1073-2322

Lally, F.J., Ratcliff, H. and Bone, A (2001) Apoptosis and disease progression in the spontaneously diabetic BB/S rat Diabetologia, 44 (3). pp. 320-324. ISSN 1432-0428

Liaudet, L., Mabley, J.G., Soriano, F.G., Pacher, P., Marton, A., Hasko, G. and Szabo, C. (2001) Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture American Journal of Respiratory and Critical Care Medicine, 164 (7). pp. 1213-1220. ISSN 1073-449X

Mabley, J.G., Hasko, G., Liaudet, L., Soriano, F.G., Southan, G.J., Salzman, A.L. and Szabo, C. (2002) NFkappaB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes Journal of Endocrinology, 173 (3). pp. 457-464. ISSN 0022-0795

Mabley, J.G., Jagtap, P., Perretti, M., Getting, S.J., Salzman, A.L., Virag, L., Szabo, E., Soriano, F.G., Liaudet, L., Abdelkarim, G.E., Hasko, G., Marton, A., Southan, G.J. and Szabo, C. (2001) Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase Inflammation research, 50 (11). pp. 561-569. ISSN 1023-3830

Mabley, J.G., Liaudet, L., Pacher, P., Southan, G.J., Salzman, A.L. and Szabo, C. (2002) Part II: beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis Molecular Medicine, 8 (10). pp. 581-590. ISSN 1076-1551

Mabley, J.G., Suarez-Pinzon, W.L., Hasko, G., Salzman, A.L., Rabinovitch, A., Kun, E. and Szabo, C. (2001) Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes British Journal of Pharmacology, 133 (6). pp. 909-919. ISSN 0007-1188

Mikhalovsky, S.V. (2003) Emerging technologies in extracorporeal treatment: focus on adsorption Perfusion, 18 (1). pp. 47-54. ISSN 1477-111X

Moghimi, S.M. and Hunter, A.C. (2001) Capture of stealth nanoparticles by the body’s defences Critical reviews in therapeutic drug carrier systems, 18 (6). pp. 527-550. ISSN 0743-4863

Moghimi, S.M., Hunter, A.C. and Murray, J.C. (2001) Long-circulating and target-specific nanoparticles: theory to practice Pharmacological Reviews, 53 (2). pp. 283-318. ISSN 1521-0081

Murray, J.C. and Moghimi, S.M. (2003) Endothelial cells as therapeutic targets in cancer: new biology and novel delivery systems Critical reviews in therapeutic drug carrier systems, 20 (2-3). pp. 139-152. ISSN 0743-4863

Pacher, P., Liaudet, L., Bai, P., Mabley, J.G., Kaminski, P.M., Virag, L., Deb, A., Szabo, E., Ungvari, Z., Wolin, M.S., Groves, J.T. and Szabo, C. (2003) Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction Circulation, 107 (6). pp. 896-904. ISSN 1524-4539

Pacher, P., Liaudet, L., Bai, P., Virag, L., Mabley, J.G., Hasko, G. and Szabo, C. (2002) Activation of poly(ADP-Ribose) polymerase contributes to development of doxorubicin-induced heart failure Journal of Pharmacology and Experimental Therapeutics, 300 (3). pp. 862-867. ISSN 1521-0103

Pacher, P., Liaudet, L., Mabley, J.G., Komjati, K. and Szabo, C. (2002) Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure Journal of the American College of Cardiology, 40 (5). pp. 1006-1016. ISSN 0735-1097

Pacher, P., Vaslin, A., Benko, R., Mabley, J.G., Liaudet, L., Hasko, G., Marton, A., Batkai, S., Kollai, M. and Szabo, C. (2004) A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging Journal of Pharmacology and Experimental Therapeutics, 311. pp. 485-491. ISSN 1521-0103

Sarker, D.K. (2005) Engineering of nanoemulsions for drug delivery Current drug delivery, 2 (4). pp. 297-310. ISSN 1567-2018

Scott, G.S., Kean, R.B., Mikheeva, T., Fabis, M.J., Mabley, J.G., Szabo, C. and Hooper, D.C. (2004) The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl) -N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation Journal of Pharmacology and Experimental Therapeutics, 310. pp. 1053-1061. ISSN 1521-0103

Sigfrid, L.A., Cunningham, J.M., Beeharry, N., Borg, L.A.H., Hernandez, A.L.R., Carlsson, C., Bone, A and Green, I.C. (2004) Antioxidant enzyme activity and mRNA expression in the islets of Langerhans from the BB/S rat model of type 1 diabetes and an insulin-producing cell line Journal of Molecular Medicine, 82. pp. 325-335. ISSN 1432-1440

Sivarajah, A., Chatterjee, P.K., Patel, N.S.A., Todorofic, Z., Hattori, Y., Brown, P.A.J., Stewart, K.N., Mota-Filipe, H., Cuzzocrea, S. and Thiemermann, C. (2003) Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury American Journal of Nephrology, 23 (4). pp. 267-276.

Smart, J.D. (2004) Lectin-mediated drug delivery in the oral cavity Advanced drug delivery reviews, 56 (4). pp. 481-489. ISSN 0169-409X

Smart, J.D. (2004) Recent developments in the use of bioadhesive systems for delivery of drugs to the oral cavity Critical reviews in therapeutic drug carrier systems, 21 (4). pp. 319-344. ISSN 0743-4863

Smart, J.D. (2005) The basics and underlying mechanisms of mucoadhesion Advanced drug delivery reviews, 57 (11). pp. 1556-1568. ISSN 0169-409X

Smart, J.D., Banchonglikitkul, C., Gibbs, R.V., Donovan, S.J. and Cook, D.J. (2003) Lectins in drug delivery to the oral cavity, in vitro toxicity studies STP Pharma Sciences, 13. pp. 37-40. ISSN 1157-1489

Soriano, F.G., Pacher, P., Mabley, J.G., Liaudet, L. and Szabo, C. (2001) Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-Ribose) polymerase Circulation Research, 89 (8). pp. 684-691. ISSN 0009-7330

Suarez-Pinzon, W.L., Mabley, J.G., Power, R., Szabo, C. and Rabinovitch, A. (2003) Poly (ADP-Ribose) polymerase inhibition prevents spontaneous and recurrent autoimmune diabetes in NOD mice by inducing apoptosis of islet-infiltrating leukocytes Diabetes, 52 (7). pp. 1683-1688. ISSN 0012-1797

Szabo, C., Pacher, P., Zsengeller, Z., Vaslin, A., Komjati, K., Benko, R., Chen, M., Mabley, J.G. and Kollai, M. (2004) Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation Molecular Medicine, 10 (1-6). pp. 28-35. ISSN 1107-3756

Thiemermann, C., Patel, N.S.A., Kvale, E.O., Cockerill, G.W., Brown, P.A.J., Stewart, K.N., Cuzzocrea, S., Britti, D., Mota-Filipe, H. and Chatterjee, P.K. (2003) High density lipoprotein (HDL)reduces renal ischemia/reperfusion injury Journal of the American Society of Nephrology, 14 (7). pp. 1833-1843. ISSN 1046-6673

Virag, L., Bai, P., Bak, I., Pacher, P., Mabley, J.G., Liaudet, L., Bakondl, E. and Gergely, P. (2004) Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma Medical Science Monitor, 10 (3). pp. 77-83. ISSN 1643-3750